Pharma Focus Asia

Sterling Invests $8 Million to Expand its Million, Micronisation and Solid Form Capabilities


Sterling Pharma Solutions invests $8 Million into a new facility at its UK to strengthen and expand its milling, micronisation and solid form capabilities.


The contract development and manufacturing organization will meet growing demand for pharmaceutical API particle size control technology.

It will meet Sterling’s laboratory capabilities to provide a full solid form offering including polymorph screening, salt selection and particle engineering and crystallization scale-up.

Four new milling areas will contain a range of new technologies, including mechanical milling, spiral jet milling and small lab scale trial mills.

The facility will also provide containment to handle OEB 4 classified molecules and offer ISO 8 cleanroom environments by supporting the CDMO’s expertise in handling potent and hazardous materials.

This latest investment helps Sterling to cater for growing market demands including the necessity for high potency capabilities to reflect the global drug pipeline.

The new facility will strengthen current offerings of Sterling by adding additional milling, micronisation and solid form capabilities.

It is expected to be operation by mid 2018. The milling, micronisation and solid form facility will create more than 15 jobs over the next 18 months, bringing Sterling’s total workforce to around 400 employees.

By expanding these capabilities, Sterling plans to ensure the diverse needs of customers globally. 


NameSterling Pharma Solutions
LocationUnited Kingdom (UK)
Parties InvolvedSterling Pharma Solutions
Budget$8 Million


magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference